NLS PHARMACEUTICS LTD (NLSP) Stock Cash Flow
NASDAQ:NLSP - Nasdaq - CH1384053976 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.98M | -12.17M | -16.50M | -11.95M | -2.86M | |||
| Depreciation Amortization | 3.30K | 11.40K | 10.00K | 10.00K | N/A | |||
| Change In Working Capital | 77.70K | 2.25M | 1.63M | -3.17M | 2.06M | |||
| Interest Paid | 500.00 | 145.20K | 10.00K | 340.00K | N/A | |||
| Other non cash items | -2.37M | 224.40K | 980.00K | 170.00K | 70.00K | |||
| OPERATING CASH FLOW | -4.27M | -9.68M | -13.88M | -14.94M | -730.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.90K | 0.00 | 0.00 | -40.00K | N/A | |||
| INVESTING CASH FLOW | -3.90K | 0.00 | 0.00 | -40.00K | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 1.63M | 830.00K | -2.10M | 1.19M | |||
| Stock Issued/Repurchased | 5.43M | 0.00 | 16.57M | 22.44M | N/A | |||
| Other Financing Activity | -386.30K | N/A | 0.00 | 0.00 | -690.00K | |||
| FINANCING CASH FLOW | 5.04M | 1.63M | 17.40M | 20.34M | 500.00K | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | -20.00K | 100.00K | |||
| CHANGE IN CASH | 767.70K | -8.05M | 3.52M | 5.34M | -130.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.27M | -9.68M | -13.88M | -14.94M | -730.00K | |||
| Capital Expenditure | -3.90K | 0.00 | 0.00 | -40.00K | N/A | |||
| FREE CASH FLOW | -4.27M | -9.68M | -13.88M | -14.98M | -730.00K | |||
All data in USD